{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:43:23Z","timestamp":1760183003468,"version":"build-2065373602"},"reference-count":73,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.rdc.2019.04.003","type":"journal-article","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T08:25:21Z","timestamp":1558945521000},"page":"399-416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Is There a Place for Hematopoietic Stem Cell Transplantation in Rheumatology?"],"prefix":"10.1016","volume":"45","author":[{"given":"Julia","family":"Spierings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob M.","family":"van Laar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.rdc.2019.04.003_bib1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7861\/clinmedicine.18-4-329","article-title":"Autologous haematopoietic stem cell transplantation (aHSCT) for severe resistant autoimmune and inflammatory diseases - a guide for the generalist","volume":"18","author":"Snowden","year":"2018","journal-title":"Clin Med (Lond)"},{"issue":"10","key":"10.1016\/j.rdc.2019.04.003_bib2","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.bbmt.2012.06.003","article-title":"Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research","volume":"18","author":"Pasquini","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.rdc.2019.04.003_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/bmt.2008.424","article-title":"Allogeneic hematopoietic SCT for patients with autoimmune diseases","volume":"44","author":"Daikeler","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.rdc.2019.04.003_bib4","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/bmt.2011.185","article-title":"Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation","volume":"47","author":"Snowden","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.rdc.2019.04.003_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.imlet.2017.11.005","article-title":"Autologous hematopoietic stem cell transplantation in systemic sclerosis: a reset to tolerance?","volume":"195","author":"van Rhijn-Brouwer","year":"2018","journal-title":"Immunol Lett"},{"issue":"3","key":"10.1016\/j.rdc.2019.04.003_bib6","first-page":"451","article-title":"Analysis of anti-topoisomerase I antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation","volume":"56","author":"Henes","year":"2017","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.rdc.2019.04.003_bib7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1182\/bloodadvances.2017011072","article-title":"Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients","volume":"2","author":"Arruda","year":"2018","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.rdc.2019.04.003_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13045-016-0388-5","article-title":"Long-term immune reconstitution and T\u00a0cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients","volume":"10","author":"Farge","year":"2017","journal-title":"J\u00a0Hematol Oncol"},{"issue":"2","key":"10.1016\/j.rdc.2019.04.003_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/imm.12245","article-title":"Immunological characteristics and T-cell receptor clonal diversity in children with systemic juvenile idiopathic arthritis undergoing T-cell-depleted autologous stem cell transplantation","volume":"142","author":"Wu","year":"2014","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.rdc.2019.04.003_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1182\/blood-2015-06-649145","article-title":"Autologous stem cell transplantation aids autoimmune patients by functional renewal and TCR diversification of regulatory T\u00a0cells","volume":"127","author":"Delemarre","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.rdc.2019.04.003_bib11","first-page":"494","article-title":"Good outcome of severe lupus patients with high-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation: a 10-year follow-up study","volume":"35","author":"Leng","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2019.04.003_bib12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood-2008-07-168286","article-title":"Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system","volume":"113","author":"Alexander","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.rdc.2019.04.003_bib13","first-page":"500","article-title":"Autologous peripheral blood haematopoietic stem cell transplantation for systemic lupus erythematosus: the observation of long-term outcomes in a Chinese centre","volume":"35","author":"Cao","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2019.04.003_bib14","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/art.21036","article-title":"Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis","volume":"52","author":"Farge","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2019.04.003_bib15","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3899\/jrheum.081025","article-title":"Immunological reconstitution after autologous hematopoietic stem cell transplantation in patients with systemic sclerosis: relationship between clinical benefits and intensity of immunosuppression","volume":"36","author":"Bohgaki","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2019.04.003_bib16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20041679","article-title":"Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients","volume":"201","author":"Muraro","year":"2005","journal-title":"J\u00a0Exp Med"},{"issue":"1","key":"10.1016\/j.rdc.2019.04.003_bib17","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/ar1452","article-title":"Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia","volume":"7","author":"Ponchel","year":"2005","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.rdc.2019.04.003_bib18","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1136\/annrheumdis-2012-202216","article-title":"Foxp3+ Helios+ regulatory T\u00a0cells are expanded in active systemic lupus erythematosus","volume":"72","author":"Alexander","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"27","key":"10.1016\/j.rdc.2019.04.003_bib19","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1182\/bloodadvances.2017010041","article-title":"Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases","volume":"1","author":"Snowden","year":"2017","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.rdc.2019.04.003_bib20","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2019.04.003_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.amjmed.2004.04.031","article-title":"Mortality in systemic sclerosis: an international meta-analysis of individual patient data","volume":"118","author":"Ioannidis","year":"2005","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.rdc.2019.04.003_bib22","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.rdc.2019.04.003_bib23","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1093\/rheumatology\/kew224","article-title":"BSR and BHPR guideline for the treatment of systemic sclerosis","volume":"55","author":"Denton","year":"2016","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.rdc.2019.04.003_bib24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2009.013458","article-title":"Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases","volume":"95","author":"Farge","year":"2010","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.rdc.2019.04.003_bib25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3899\/jrheum.110868","article-title":"Optimization of autologous stem cell transplantation for systemic sclerosis \u2013 a single-center longterm experience in 26 patients with severe organ manifestations","volume":"39","author":"Henes","year":"2012","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2019.04.003_bib26","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood-2007-02-072389","article-title":"High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study","volume":"110","author":"Nash","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.rdc.2019.04.003_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/bmt.2016.211","article-title":"Autologous hematopoietic stem cell transplantation has better outcomes than conventional therapies in patients with rapidly progressive systemic sclerosis","volume":"52","author":"Del Papa","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"24","key":"10.1016\/j.rdc.2019.04.003_bib28","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.rdc.2019.04.003_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1703327","article-title":"Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"9790","key":"10.1016\/j.rdc.2019.04.003_bib30","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.rdc.2019.04.003_bib31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jbspin.2013.09.003","article-title":"Prevalence and incidence of juvenile idiopathic arthritis: a systematic review","volume":"81","author":"Thierry","year":"2014","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.rdc.2019.04.003_bib32","doi-asserted-by":"crossref","first-page":"c6434","DOI":"10.1136\/bmj.c6434","article-title":"Diagnosis and management of juvenile idiopathic arthritis","volume":"341","author":"Prince","year":"2010","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.rdc.2019.04.003_bib33","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1182\/blood-2005-07-2800","article-title":"Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T\u00a0cells and restoring the CD4+CD25+ immune regulatory network","volume":"107","author":"de Kleer","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.rdc.2019.04.003_bib34","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.22656","article-title":"Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial","volume":"56","author":"Brinkman","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2019.04.003_bib35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.molimm.2008.12.029","article-title":"Autologous T cell depleted hematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000\u20132007)","volume":"47","author":"Abinun","year":"2009","journal-title":"Mol Immunol"},{"issue":"7","key":"10.1016\/j.rdc.2019.04.003_bib36","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1182\/bloodadvances.2017014449","article-title":"Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis","volume":"2","author":"Silva","year":"2018","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.rdc.2019.04.003_bib37","first-page":"482","article-title":"Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR","volume":"31","author":"Snowden","year":"2004","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2019.04.003_bib38","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/1529-0131(200104)44:4<754::AID-ANR131>3.0.CO;2-N","article-title":"High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy","volume":"44","author":"Verburg","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.rdc.2019.04.003_bib39","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1136\/ard.2004.034793","article-title":"High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: poor response associated with persistence of host autoantibodies and synovial abnormalities","volume":"64","author":"van Oosterhout","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.rdc.2019.04.003_bib40","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/art.10495","article-title":"A\u00a0pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis","volume":"46","author":"Moore","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2019.04.003_bib41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/rheumatology\/kew377","article-title":"Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus","volume":"56","author":"Tsang","year":"2017","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.rdc.2019.04.003_bib42","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1136\/annrheumdis-2015-207347","article-title":"Prolonged remission in Caucasian patients with SLE: prevalence and outcomes","volume":"74","author":"Zen","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.rdc.2019.04.003_bib43","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/096120339700600613","article-title":"Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration","volume":"6","author":"Marmont","year":"1997","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.rdc.2019.04.003_bib44","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1191\/0961203304lu525oa","article-title":"Autologous stem cell transplantation for systemic lupus erythematosus","volume":"13","author":"Jayne","year":"2004","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.rdc.2019.04.003_bib45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/0961203312470729","article-title":"Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry","volume":"22","author":"Alchi","year":"2013","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.rdc.2019.04.003_bib46","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s41409-018-0173-x","article-title":"Five year follow-up after autologous peripheral blood hematopoietic stem cell transplantation for refractory, chronic, corticosteroid-dependent systemic lupus erythematosus: effect of conditioning regimen on outcome","volume":"53","author":"Burt","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.rdc.2019.04.003_bib47","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s10067-004-1065-6","article-title":"Use of CD34+ autologous stem cell transplantation in the treatment of children with refractory systemic lupus erythematosus","volume":"24","author":"Chen","year":"2005","journal-title":"Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2019.04.003_bib48","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00296-016-3531-2","article-title":"Long-term follow-up of fertility and pregnancy in autoimmune diseases after autologous haematopoietic stem cell transplantation","volume":"36","author":"Massenkeil","year":"2016","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.rdc.2019.04.003_bib49","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.transproceed.2007.01.070","article-title":"Hematopoietic stem cell transplantation in\u00a0autoimmune diseases: the Ahmedabad experience","volume":"39","author":"Vanikar","year":"2007","journal-title":"Transplant Proc"},{"issue":"7","key":"10.1016\/j.rdc.2019.04.003_bib50","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1177\/0961203316669242","article-title":"Long-term systemic lupus erythematosus disease control after allogeneic bone marrow transplantation","volume":"26","author":"Gladstone","year":"2017","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.rdc.2019.04.003_bib51","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.autrev.2017.03.008","article-title":"Autologous hematopoietic stem cell transplantation in Systemic Lupus Erythematosus and antiphospholipid syndrome: a systematic review","volume":"16","author":"Leone","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.rdc.2019.04.003_bib52","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2005-01-0330","article-title":"Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation","volume":"106","author":"Statkute","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.rdc.2019.04.003_bib53","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/ard.2006.056630","volume":"66","author":"Daikeler","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.rdc.2019.04.003_bib54","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/rheumatology\/ket479","article-title":"Bone marrow transplantation for Behcet's disease: a case report and systematic review of the literature","volume":"53","author":"Soysal","year":"2014","journal-title":"Rheumatology"},{"issue":"4 Pt 2","key":"10.1016\/j.rdc.2019.04.003_bib55","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/pr.2011.57","article-title":"Complications of autologous hematopoietic stem cell transplantation for patients with autoimmune diseases","volume":"71","author":"Daikeler","year":"2012","journal-title":"Pediatr Res"},{"issue":"5","key":"10.1016\/j.rdc.2019.04.003_bib56","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1586\/ehm.09.48","article-title":"Late complications after hematopoietic stem cell transplantation","volume":"2","author":"Tichelli","year":"2009","journal-title":"Expert Rev Hematol"},{"issue":"17","key":"10.1016\/j.rdc.2019.04.003_bib57","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1001\/jama.2014.12572","article-title":"Cardiac assessment before stem cell transplantation for systemic sclerosis\u2014reply","volume":"312","author":"van Laar","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.rdc.2019.04.003_bib58","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/BOR.0000000000000541","article-title":"Hematopoietic stem-cell transplantation in systemic sclerosis: an update","volume":"30","author":"Spierings","year":"2018","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2019.04.003_bib59","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3899\/jrheum.111302","article-title":"Hematopoietic stem cell transplantation for systemic sclerosis: if you are confused, remember: \u201cit is a matter of the heart\u201d","volume":"39","author":"Burt","year":"2012","journal-title":"J\u00a0Rheumatol"},{"issue":"9790","key":"10.1016\/j.rdc.2019.04.003_bib60","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0140-6736(11)61100-8","article-title":"Autologous HSCT in systemic sclerosis: a step forward","volume":"378","author":"Farge","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2019.04.003_bib61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaut.2018.06.002","article-title":"Hematopoietic stem cell therapy for autoimmune diseases - Clinical experience and mechanisms","volume":"92","author":"Alexander","year":"2018","journal-title":"J\u00a0Autoimmun"},{"issue":"11","key":"10.1016\/j.rdc.2019.04.003_bib62","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/bmt.2017.56","article-title":"Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners","volume":"52","author":"Farge","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.rdc.2019.04.003_bib63","first-page":"2236","article-title":"Estimating the burden of scleroderma disease in Spain","volume":"34","author":"Villaverde-Hueso","year":"2007","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2019.04.003_bib64","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3109\/03009742.2014.976653","article-title":"The economic burden and health-related quality of life associated with systemic sclerosis in France","volume":"44","author":"Chevreul","year":"2015","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2019.04.003_bib65","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s10067-013-2373-5","article-title":"Health-care utilization in Dutch systemic sclerosis patients","volume":"33","author":"Meijs","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"1 Suppl","key":"10.1016\/j.rdc.2019.04.003_bib66","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.bbmt.2009.10.034","article-title":"Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States","volume":"16","author":"Sullivan","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.rdc.2019.04.003_bib67","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/bmt.2012.133","article-title":"Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: a study using a large national private claims database","volume":"48","author":"Majhail","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.rdc.2019.04.003_bib68","first-page":"366","article-title":"The cost of hematopoietic stem-cell transplantation in the United States","volume":"10","author":"Broder","year":"2017","journal-title":"Am Health Drug Benefits"},{"issue":"3","key":"10.1016\/j.rdc.2019.04.003_bib69","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.gtc.2014.05.001","article-title":"Risk of infections with biological agents","volume":"43","author":"Kopylov","year":"2014","journal-title":"Gastroenterol Clin North Am"},{"issue":"6","key":"10.1016\/j.rdc.2019.04.003_bib70","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/bmt.2009.305","article-title":"Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis","volume":"45","author":"Tappenden","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.rdc.2019.04.003_bib71","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.bbmt.2018.04.001","article-title":"Shared decision-making in hematopoietic stem cell transplantation for sickle cell disease","volume":"24","author":"Sullivan","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.rdc.2019.04.003_bib72","first-page":"719","article-title":"High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis","volume":"28","author":"Verburg","year":"2001","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2019.04.003_bib73","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.295.5.527","article-title":"Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus","volume":"295","author":"Burt","year":"2006","journal-title":"JAMA"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X19300304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X19300304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:18:11Z","timestamp":1760181491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X19300304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0889857X19300304"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2019.04.003","relation":{},"ISSN":["0889-857X"],"issn-type":[{"type":"print","value":"0889-857X"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is There a Place for Hematopoietic Stem Cell Transplantation in Rheumatology?","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2019.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}